The activation of STAT3 signaling pathway in IL-22-induced epithelial cells increases the cell survival and inhibits apoptosis, which is indicative of the importance of this signaling pathway in progressing IBD to cancer [112]. This evidence concerns the gene IL22 and inflammatory bowel disease.